{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:55Z","timestamp":1759366075433,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.nefro.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T17:28:28Z","timestamp":1592501308000},"page":"640-646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How to improve adherence the captors of phosphorus on hemodialysis: Experience in real life with sucroferric oxyhydroxide"],"prefix":"10.1016","volume":"40","author":[{"given":"M. Dolores","family":"Arenas Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"Navarro Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2020.04.011_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","article-title":"The phosphate binder equivalent dose","volume":"24","author":"Daugirdas","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.nefro.2020.04.011_bib0125","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2020.04.011_bib0130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s10157-012-0640-4","article-title":"Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study","volume":"16","author":"Iimori","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2369-15-71","article-title":"Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial","volume":"15","author":"Ure\u00f1a-Torres","year":"2014","journal-title":"BMC Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2020.04.011_bib0140","first-page":"1","article-title":"Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2020.04.011_bib0145","first-page":"290","article-title":"Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS)","volume":"21","author":"Cannata-And\u00eda","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ndt\/gfv006","article-title":"Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients","volume":"30","author":"Floege","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2020.04.011_bib0155","first-page":"525","article-title":"Challenge of phosphorus control in hemodialysis patients: a problem of adherence?","volume":"23","author":"Arenas","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-9-2","article-title":"A systematic review of the prevalence and determinants of non adherence to phosphate binding medication in patients with end-stage renal disease","volume":"9","author":"Karamanidou","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hdi.12315","article-title":"Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: findings from the DOPPS","volume":"20","author":"Fissell","year":"2016","journal-title":"Hemodialysis Int"},{"key":"10.1016\/j.nefro.2020.04.011_bib0170","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.nefro.2020.04.011_bib0175","first-page":"1","article-title":"Patient-reported factors associated with poor phosphorus control in a maintenance hemodialysis population","author":"Joson","year":"2015","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nefro.2020.04.011_bib0180","first-page":"522","article-title":"Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control","volume":"30","author":"Arenas","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2020.04.011_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN109054","article-title":"A strategy based on patient preference improves the adherence and outcomes of phosphate binders in hemodialysis","volume":"88","author":"Arenas Jim\u00e9nez","year":"2017","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00002030-200203080-00012","article-title":"Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA study","volume":"16","author":"Knobel","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.nefro.2020.04.011_bib0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5414\/CN109021","article-title":"Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: a retrospective analysis of pharmacy data","volume":"88","author":"Coyne","year":"2017","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0200","first-page":"S158","article-title":"Physician estimates of adherence and the patient-physician relationship as a setting to improve Adherence to antiretroviral therapy","volume":"31","author":"Murri","year":"2002","journal-title":"JAIDS"},{"key":"10.1016\/j.nefro.2020.04.011_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.2002.09004.x","article-title":"How well do clinicians estimate patients\u2019 adherence to combination antiretroviral therapy?","volume":"17","author":"Miller","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.nefro.2020.04.011_bib0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2020.04.011_bib0215","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1471-2369-14-208","article-title":"Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis","volume":"3","author":"Martins","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefro.2020.04.011_bib0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.jrn.2013.11.004","article-title":"Reasons for phosphate binder discontinuation vary by binder type","volume":"24","author":"Wang","year":"2014","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nefro.2020.04.011_bib0225","doi-asserted-by":"crossref","first-page":"e002749","DOI":"10.1136\/bmjopen-2013-002749","article-title":"A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence","volume":"3","author":"Easthall","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.nefro.2020.04.011_bib0230","series-title":"The power of belief: psychosocial influence on illness. Disability and medicine","first-page":"115","article-title":"Beliefs and adherence to treatment: the challenge for research and clinical practice","author":"Horne","year":"2006"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699520300680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699520300680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:54:03Z","timestamp":1759323243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699520300680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0211699520300680"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2020.04.011","relation":{},"ISSN":["0211-6995"],"issn-type":[{"type":"print","value":"0211-6995"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to improve adherence the captors of phosphorus on hemodialysis: Experience in real life with sucroferric oxyhydroxide","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}